Literature DB >> 16235239

Recurrent coamplification of cytoskeleton-associated genes EMS1 and SHANK2 with CCND1 in oral squamous cell carcinoma.

Kolja Freier1, Carsten Sticht, Christof Hofele, Christa Flechtenmacher, Daniel Stange, Laura Puccio, Grischa Toedt, Bernhard Radlwimmer, Peter Lichter, Stefan Joos.   

Abstract

Chromosomal band 11q13 is frequently amplified in oral squamous cell carcinoma (OSCC) and assumed to be critically involved in tumor initiation and progression by proto-oncogene activation. Though cyclin D1 (CCND1) is supposed to be the most relevant oncogene, several additional putative candidate genes are inside this chromosomal region, for which their actual role in tumorigenesis still needs to be elucidated. To characterize the 11q13 amplicon in detail, 40 OSCCs were analyzed by comparative genomic hybridization to DNA microarrays (matrix-CGH) containing BAC clones derived from chromosomal band 11q13. This high-resolution approach revealed a consistent amplicon about 1.7 Mb in size including the CCND1 oncogene. Seven BAC clones covering FGF3, EMS1, and SHANK2 were shown to be frequently coamplified inside the CCND1 amplicon. Subsequent analysis of tissue microarrays by FISH revealed amplification frequencies of 36.8% (88/239) for CCND1, 34.3% (60/175) for FGF3, 37.4% (68/182) for EMS1, and 36.3% (61/168) for SHANK2. Finally, quantitative mRNA expression analysis demonstrated consistent overexpression of CCND1 in all tumors and of EMS1 and SHANK2 in a subset of specimens with 11q13 amplification, but no expression of FGF3 in any of the cases. Our study underlines the critical role of CCND1 in OSCC development and additionally points to the functionally related genes EMS1 and SHANK2, both encoding for cytoskeleton-associated proteins, which are frequently coamplified with CCND1 and therefore could cooperatively contribute to OSCC pathogenesis.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16235239     DOI: 10.1002/gcc.20270

Source DB:  PubMed          Journal:  Genes Chromosomes Cancer        ISSN: 1045-2257            Impact factor:   5.006


  23 in total

1.  High-resolution mapping identifies a commonly amplified 11q13.3 region containing multiple genes flanked by segmental duplications.

Authors:  Johan H Gibcus; Klaas Kok; Lorian Menkema; Mario A Hermsen; Mirjam Mastik; Philip M Kluin; Jacqueline E van der Wal; Ed Schuuring
Journal:  Hum Genet       Date:  2006-12-15       Impact factor: 4.132

2.  Heterogeneity of 11q13 region rearrangements in laryngeal squamous cell carcinoma analyzed by microarray platforms and fluorescence in situ hybridization.

Authors:  Małgorzata Jarmuz-Szymczak; Kinga Pelinska; Magdalena Kostrzewska-Poczekaj; Ewa Bembnista; Maciej Giefing; Damian Brauze; Marcin Szaumkessel; Andrzej Marszalek; Joanna Janiszewska; Katarzyna Kiwerska; Anna Bartochowska; Reidar Grenman; Witold Szyfter; Krzysztof Szyfter
Journal:  Mol Biol Rep       Date:  2013-05-08       Impact factor: 2.316

3.  Genetic gains and losses in oral squamous cell carcinoma: impact on clinical management.

Authors:  Ilda Patrícia Ribeiro; Francisco Marques; Francisco Caramelo; João Pereira; Miguel Patrício; Hugo Prazeres; José Ferrão; Maria José Julião; Miguel Castelo-Branco; Joana Barbosa de Melo; Isabel Poiares Baptista; Isabel Marques Carreira
Journal:  Cell Oncol (Dordr)       Date:  2013-12-19       Impact factor: 6.730

4.  CCND1 amplification and cyclin D1 immunohistochemical expression in head and neck squamous cell carcinomas.

Authors:  Henning Hanken; Alexander Gröbe; Georg Cachovan; Ralf Smeets; Ronald Simon; Guido Sauter; Max Heiland; Marco Blessmann
Journal:  Clin Oral Investig       Date:  2013-03-15       Impact factor: 3.573

5.  Tumor transcriptome sequencing reveals allelic expression imbalances associated with copy number alterations.

Authors:  Brian B Tuch; Rebecca R Laborde; Xing Xu; Jian Gu; Christina B Chung; Cinna K Monighetti; Sarah J Stanley; Kerry D Olsen; Jan L Kasperbauer; Eric J Moore; Adam J Broomer; Ruoying Tan; Pius M Brzoska; Matthew W Muller; Asim S Siddiqui; Yan W Asmann; Yongming Sun; Scott Kuersten; Melissa A Barker; Francisco M De La Vega; David I Smith
Journal:  PLoS One       Date:  2010-02-19       Impact factor: 3.240

6.  Multiple pathways in the FGF signaling network are frequently deregulated by gene amplification in oral dysplasias.

Authors:  Ivy F L Tsui; Catherine F Poh; Cathie Garnis; Miriam P Rosin; Lewei Zhang; Wan L Lam
Journal:  Int J Cancer       Date:  2009-11-01       Impact factor: 7.396

7.  Copy number gain and oncogenic activity of YWHAZ/14-3-3zeta in head and neck squamous cell carcinoma.

Authors:  Mauting Lin; Carl D Morrison; Susie Jones; Nehad Mohamed; Jason Bacher; Christoph Plass
Journal:  Int J Cancer       Date:  2009-08-01       Impact factor: 7.396

Review 8.  Cortactin in tumor invasiveness.

Authors:  Alissa M Weaver
Journal:  Cancer Lett       Date:  2008-04-10       Impact factor: 8.679

9.  A novel prognostic biomarker for muscle invasive bladder urothelial carcinoma based on 11 DNA methylation signature.

Authors:  Yueyi Feng; Yiqing Jiang; Qingting Feng; Lingkai Xu; Yun Jiang; Fang Meng; Xiaochen Shu
Journal:  Cancer Biol Ther       Date:  2020-11-05       Impact factor: 4.742

10.  Aggressiveness of HNSCC tumors depends on expression levels of cortactin, a gene in the 11q13 amplicon.

Authors:  E S Clark; B Brown; A S Whigham; A Kochaishvili; W G Yarbrough; A M Weaver
Journal:  Oncogene       Date:  2008-10-20       Impact factor: 9.867

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.